Roche immunotherapy combination increases lung cancer survival-study – Reuters
Reuters |
Roche immunotherapy combination increases lung cancer survival-study
Reuters (Reuters) – Roche’s immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage … |
Digital Trends |
Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA
Digital Trends Did we somehow wake up in a Michael Crichton novel without realizing it? First, Harvard University sets out to bring the woolly mammoth back to life. Now, researchers from Germany’s Max Planck Institute for Evolutionary Anthropology have stated their … |
Digital Trends |
Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA
Digital Trends Did we somehow wake up in a Michael Crichton novel without realizing it? First, Harvard University sets out to bring the woolly mammoth back to life. Now, researchers from Germany’s Max Planck Institute for Evolutionary Anthropology have stated their … |
In Vivo |
Deal Watch: Novo’s Increased Cell Therapy Commitment Includes Stem Cell Pact With BioLamina
In Vivo Also, TapImmune merger with Marker could yield T-cell therapies that address multiple tumor-associated antigens with a better safety profile than CAR-T therapy. Bluebird and Medigene expand their TCR therapy collaboration. Already Registered? Sign in … |
Nikkei Asian Review |
Japan keeps edge in stem–cell medicine with heart study
Nikkei Asian Review TOKYO/OSAKA — Japan’s decision on Wednesday to greenlight a study using stem cells for treating heart failure shows how far the field has progressed in the decade since the cells were first developed. The health ministry approved Osaka University’s … |